Skip to main content
Premium Trial:

Request an Annual Quote

54gene: Ron Chiarello, Teresia Bos, Tobi Oke, Temi Awogboro

54gene has promoted Ron Chiarello to CEO. He had been co-CEO since the beginning of the year with Teresia Bost, who had been serving in an interim capacity since October. Prior to joining 54gene, Chiarello was founder, CEO, and chairman of Alveo Technologies. 

Bost remains with the company as an advisor.

54gene also appointed Tobi Oke, managing partner of Nigeria-based venture capital fund V8 Capital Partners, to its board of directors. Additionally, the company said that another African venture capitalist, Temi Awogboro, will serve as an advisor and an observer on the board.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.